HealthMedPage Today
About a Quarter of Those Who Stop Wegovy Start Again
(MedPage Today) -- Nearly half of adults who started semaglutide (Wegovy) for obesity management stopped treatment within a year, a Danish cohort study showed. Among 157,822 first-time semaglutide initiators without diabetes, 49% discontinued...
Join the argument
House rules βComments load as you scroll.